VT-105
Pou rechèch syantifik sèlman, pa pou pasyan yo.
Pwodwi detay
Tags pwodwi
| Gwosè pake | Disponibilite | Pri (USD) |
| 0.1G | Nan Stock | 360 |
| 0.5G | Nan Stock | 790 |
| 1G | Nan Stock | 1050 |
Non Chimik:
(S)-N-(1-(piridin-2-yl)etil)-8-(4-(trifluorometil)fenil)quinoline-3-carboxamide
Kòd SMILES:
FC(F)(F)C(C=C1)=CC=C1C2=CC=CC3=CC(C(N[C@@H](C)C4=NC=CC=C4)=O)=CN= C23
Kòd InChi:
InChI=1S/C24H18F3N3O/c1-15(21-7-2-3-12-28-21)30-23(31)18-13-17-5-4-6-20(22(17)29- 14-18)16-8-10-19(11-9-16)24(25,26)27/h2-15H,1H3,(H,30,31)/t15-/m0/s1
InChi kle:
FUKXXBXVSANFJK-HNNXBMFYSA-N
Mot:
2417718-38-6;CAS:2417718-38-6;CAS:2417718-38-6;VT-105; VT 105; VT105
Solibilite:
Depo:Sèk, nwa ak nan 0 - 4 C pou kout tèm (jou a semèn) oswa -20 C pou tèm long (mwa a ane).
Deskripsyon:
VT-105 se yon inibitè ki pisan ak selektif TEAD pwòp tèt ou palmitoylation.
Sib: TEAD


![4H-1,3-Dioxolo[4,5-c]pyrrole-4-carboxamide, N-(3-chloro-4-fluorophenyl)tetrahydro-N,2,2-trimethyl-6-oxo-, (3aS,4S ,6aS)-](http://www.caerulumpharm.com/uploads/20240605095550.jpg)




